Translational Research
Volume 156, Issue 5 , Pages 273-281 , November 2010

Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock

  • Ole-Jakob How

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • Corresponding Author InformationReprint requests: Ole-Jakob How, Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, N-9037 Tromsø, Norway
    • ,
  • Assami Røsner

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Anders B. Kildal

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Thor A. Stenberg

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Petter F. Gjessing

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • ,
  • Stig E. Hermansen

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • Department of Cardiothoracic and Vascular Surgery, University Hospital North Norway, Tromsø, Norway
    • ,
  • Truls Myrmel

      Affiliations

    • Laboratory of Surgical Research, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
    • Department of Cardiothoracic and Vascular Surgery, University Hospital North Norway, Tromsø, Norway

Received 15 April 2010 ,Revised 19 July 2010 ,Accepted 21 July 2010.

References 

  1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–2442
  2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:E1–E211
  3. Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541–1547
  4. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57–64
  5. Thackray S, Easthaugh J, Freemantle N, Cleland JG. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail. 2002;4:515–529
  6. Francis GS, Sharma B, Hodges M. Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J. 1982;103:995–1000
  7. Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975;36:185–196
  8. Vatner SF, McRitchie RJ, Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest. 1974;53:1265–1273
  9. Cronin RF, Tan EH. The inotropic effect of l-noradrenaline in experimental cardiogenic shock. Can J Physiol Pharmacol. 1965;43:55–68
  10. Laks M, Callis G, Swan HJ. Hemodynamic effects of low doses of norepinephrine in the conscious dog. Am J Physiol. 1971;220:171–173
  11. Vatner SF, Knight DR, Hintze TH. Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs. Am J Physiol. 1985;249:H49–H56
  12. Stratton JR, Pfeifer MA, Halter JB. The hemodynamic effects of sympathetic stimulation combined with parasympathetic blockade in man. Circulation. 1987;75:922–929
  13. Jolly S, Newton G, Horlick E, et al. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2005;96:1617–1620
  14. Overgaard CB, Dzavik V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation. 2008;118:1047–1056
  15. Muller S, How OJ, Hermansen SE, Stenberg TA, Sager G, Myrmel T. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care. 2008;12:R20
  16. Nordhaug D, Steensrud T, Korvald C, Aghajani E, Myrmel T. Preserved myocardial energetics in acute ischemic left ventricular failure—studies in an experimental pig model. Eur J Cardiothorac Surg. 2002;22:135–142
  17. Burkhoff D. The conductance method of left ventricular volume estimation. Methodologic limitations put into perspective. Circulation. 1990;81:703–706
  18. Mirsky I. Assessment of diastolic function: suggested methods and future considerations 82. Circulation. 1984;69:836–841
  19. De BD, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–789
  20. Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes?. Crit Care. 2001;5:294–298
  21. Myrmel T, Korvald C. New aspects of myocardial oxygen consumption. Invited review. Scand Cardiovasc J. 2000;34:233–241
  22. Podzuweit T, Lubbe WF, Opie LH. Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs. Lancet. 1976;1:341–342
  23. Packer M, Medina N, Yushak M. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation. 1984;70:1038–1047
  24. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989;320:677–683
  25. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116:973–980
  26. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588–595
  27. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122–1125
  28. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol. 1983;245:H773–H780
  29. Nevo E. Constrained optimization of ventricular efficiency in normal and failing hearts. Am J Physiol. 1993;264:H1292–H1299
  30. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension. 2005;46:185–193
  31. Kass DA, Kelly RP. Ventriculo-arterial coupling: concepts, assumptions, and applications. Ann Biomed Eng. 1992;20:41–62
  32. Aghajani E, Muller S, Kjorstad KE, et al. The pressure-volume loop revisited: Is the search for a cardiac contractility index a futile cycle?. Shock. 2006;25:370–376
  33. Glower DD, Spratt JA, Snow ND, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985;71:994–1009
  34. Leite-Moreira AF, Correia-Pinto J, Gillebert TC. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc Res. 1999;43:344–353
  35. De Hert SG, Gillebert TC, Ten Broecke PW, Mertens E, Rodrigus IE, Moulijn AC. Contraction-relaxation coupling and impaired left ventricular performance in coronary surgery patients. Anesthesiology. 1999;90:748–757
  36. Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. Acute neurohumoral modulation of diastolic function. Peptides. 2009;30:419–425
  37. Muller S, How OJ, Jakobsen O, et al. Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan. Circ Heart Fail. 2010;3:277–285

 Supported by the health authorities of north Norway (“Helse Nord”).

PII: S1931-5244(10)00159-3

doi: 10.1016/j.trsl.2010.07.011

Translational Research
Volume 156, Issue 5 , Pages 273-281 , November 2010

Article Tools

* Image Usage & Resolution